Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMW-HA in acute exacerbation of COPD
NCT02674880Phase 2Completed
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Mar 2016
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sodium hyaluronate in chronic obstructive pulmonary disease (COPD), sponsored by Università Campus Bio-Medico di Roma. Started Mar 2016; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02674880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02674880.